Dogwood Therapeutics, Inc.
NASDAQ:DWTXBiotechnology
+$0.04 today
- Market cap
- $51.12M
- Beta
- 1.76
- P/E (TTM)
- -0.2
- EPS (TTM)
- -$0.84
Volume 0.12M
Average 0.09M
DWTX Total Current Assets
All assets expected to be converted to cash or used up within one year.
Dogwood Therapeutics, Inc.NASDAQ: DWTX
Total Current Assets · Q1 FY2026 · quarter ended Mar 2026
Total current assets falls 21.7% from a year ago
Total current assets stood at $15M at the end of Q1 FY2026, down 21.7% from a year earlier and up 78.0% from the prior quarter. Over 3 fiscal years it compounded at +0.2% a year.
Context
- Total current assets amounted to 15.8% of total assets at the end of Q1 FY2026, down 4.0 pp from a year earlier.
- Total current assets increased in 1 of the last 3 fiscal years.
What to watch
Whether total current assets keeps falling in the next quarterly balance sheet after a -21.7% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Current Assets history
USD · from the balance sheet
- Latest · FY2025
- 8.43M USD
- Year-over-year change
- -49.0%
- 4-year CAGR
- -14.5%
| Period | Period end | Total Current Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 8.43M | -49.0% |
| FY2024 | 2024-12-31 | 16.54M | +297.2% |
| FY2023 | 2023-12-31 | 4.17M | -50.2% |
| FY2022 | 2022-12-31 | 8.37M | -46.9% |
| FY2021 | 2021-12-31 | 15.78M | — |
Total Current Assets vs competitors
How DWTX compares with its peers on the latest reported figures
- DWTX's Mar 2026 total current assets of $15M is the highest of the 2 companies compared; the peer median is $10.42M.
- Its year-over-year change of -21.7% is the highest of 2, against a peer median of -27.6%.
- Total current assets amounts to 15.8% of total assets for DWTX, versus a peer median of 84.1%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $15M | -21.7% | +0.2% | 15.8% | |
| Mar 2026 | $10.42M | -27.6% | +8.2% | 84.1% | |
| Peer median (excluding DWTX) | $10.42M | -27.6% | +8.2% | 84.1% | |
Competitors are the stored peer set for DWTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 14.01M | 7.03M | 3.32M | 14.85M | 6.52M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 863 | 7.29K | 3.56K | 28.01K | 4.88K |
| Total Current Assets | 15.78M | 8.37M | 4.17M | 16.54M | 8.43M |
| Property, Plant & Equipment (Net) | 0 | 0 | 0 | 222.65K | 194.93K |
| Goodwill | 0 | 0 | 0 | 11.81M | 12.4M |
| Intangible Assets | 0 | 0 | 0 | 65.71M | 68.99M |
| Long-term Investments | 0 | 0 | 0 | 18.13K | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 0 | 0 | 0 | 0 | 158.96K |
| Total Non-current Assets | 0 | 0 | 0 | 77.76M | 81.74M |
| Total Assets | 15.78M | 8.37M | 4.17M | 94.31M | 90.17M |
| Account Payables | 353.86K | 573.16K | 111.91K | 1.23M | 760.95K |
| Short-term Debt | 0 | 0 | 0 | 49.7K | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 532.68K | 159.7K | 0 | 687.59K | 745.08K |
| Total Current Liabilities | 1.28M | 1.04M | 358.55K | 3.18M | 3.06M |
| Long-term Debt | 0 | 0 | 0 | 15.38M | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 11.31M | 12.11M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 0 | 0 | 0 | 0 | 0 |
| Total Non-current Liabilities | 0 | 0 | 0 | 26.85M | 12.22M |
| Total Liabilities | 1.28M | 1.04M | 358.55K | 30.03M | 15.27M |
| Common Stock | 833 | 1.83K | 77 | 133 | 2.97K |
| Retained Earnings | (43.93M) | (56.17M) | (61.47M) | (73.82M) | (108.08M) |
| Accumulated OCI | 0 | 0 | 0 | (3.86M) | (587.04K) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 14.5M | 7.33M | 3.81M | 64.28M | 74.9M |
| Total Debt | 0 | 0 | 0 | 15.59M | 162.6K |
| Net Debt | (14.01M) | (7.03M) | (3.32M) | 737.71K | (6.36M) |
Dogwood Therapeutics, Inc.
NASDAQ:DWTX
Intrinsic Alpha fair value
Locked
Current Price
$1.52
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.